Tango Therapeutics (TNGX) Assets Average (2020 - 2026)

Tango Therapeutics' Assets Average history runs 7 years deep, the most recent figure standing at $417.2 million for Q1 2026.

• In Q1 2026, Assets Average rose 41.25% year-over-year to $417.2 million; the TTM figure through Mar 2026 stood at $417.2 million (up 41.25% YoY), while the FY2025 annual figure was $357.6 million, down 0.54% from the prior year.
• Assets Average was $417.2 million for Q1 2026 at Tango Therapeutics, up from $304.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $485.8 million in Q1 2022 to a low of $224.0 million in Q3 2025.
• Historically, Assets Average has averaged $381.2 million across 5 years, with a median of $403.8 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Assets Average jumped 173.94% in 2022, then tumbled 38.95% in 2025.
• A 5-year view of Assets Average shows it stood at $450.3 million in 2022, then fell by 7.76% to $415.4 million in 2023, then dropped by 19.48% to $334.5 million in 2024, then decreased by 8.98% to $304.4 million in 2025, then jumped by 37.06% to $417.2 million in 2026.
• The last three Assets Average figures came in at $417.2 million (Q1 2026), $304.4 million (Q4 2025), and $224.0 million (Q3 2025), per Business Quant data.